{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:16:22Z","timestamp":1794017782767,"version":"4.8.0"},"reference-count":20,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2013,5,13]]},"published-print":{"date-parts":[[2013]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Evaluation of predictive value of liver function tests (LFTs) for the detection of liver-related disease in primary care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A prospective observational study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>11 UK primary care practices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Patients (n=1290) with an abnormal eight-panel LFT (but no previously diagnosed liver disease).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Patients were investigated by recording clinical features, and repeating LFTs, specific tests for individual liver diseases, and abdominal ultrasound scan. Patients were characterised as having: hepatocellular disease; biliary disease; tumours of the hepato-biliary system and none of the above. The relationship between LFT results and disease categories was evaluated by stepwise regression and logistic discrimination, with adjustment for demographic and clinical factors. True and False Positives generated by all possible LFT combinations were compared with a view towards optimising the choice of analytes in the routine LFT panel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Regression methods showed that alanine aminotransferase (ALT) was associated with hepatocellular disease (32 patients), while alkaline phosphatase (ALP) was associated with biliary disease (12 patients) and tumours of the hepatobiliary system (9 patients). A restricted panel of ALT and ALP was an efficient choice of analytes, comparing favourably with the complete panel of eight analytes, provided that 48 False Positives can be tolerated to obtain one additional True Positive. Repeating a complete panel in response to an abnormal reading is not the optimal strategy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The LFT panel can be restricted to ALT and ALP when the purpose of testing is to exclude liver disease in primary care.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2013-003099","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T00:17:42Z","timestamp":1371860262000},"page":"e003099","source":"Crossref","is-referenced-by-count":26,"title":["What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study"],"prefix":"10.1136","volume":"3","author":[{"given":"Richard J","family":"Lilford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M","family":"Bentham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Girling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"2024051504500506000_3.6.e003099.1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36061"},{"key":"2024051504500506000_3.6.e003099.2","doi-asserted-by":"crossref","unstructured":"Lilford RJ Bentham L Girling A . Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study. Health Technology Assessment, vol. 17. 2013, pp 1\u2013307.","DOI":"10.3310\/hta17280"},{"key":"2024051504500506000_3.6.e003099.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7281.276"},{"key":"2024051504500506000_3.6.e003099.4","unstructured":"World Health Organisation. Geneva: Good clinical laboratory practice (GCLP). World Health Organization on behalf of the special programme for research and training in tropical diseases. Geneva: World Health Organisation Press, 2009."},{"key":"2024051504500506000_3.6.e003099.5","unstructured":"StataCorp. Stata statistical software: release 12. College Station, TX: StataCorp LP, 2011."},{"key":"2024051504500506000_3.6.e003099.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13250","article-title":"Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)","volume":"13","author":"Donnan","year":"2009","journal-title":"Health Technol Assess"},{"key":"2024051504500506000_3.6.e003099.7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","article-title":"Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study","volume":"20","author":"Bellentani","year":"1994","journal-title":"Hepatology"},{"key":"2024051504500506000_3.6.e003099.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050965"},{"key":"2024051504500506000_3.6.e003099.9","unstructured":"Health Protection Agency. Hepatitis C Information. Health Protection Agency, 2003. http:\/\/www.hpa.org.uk\/infections\/topics_az\/hepatitis_c\/phlsgen_info.htm (accessed 25 Mar 2013)."},{"key":"2024051504500506000_3.6.e003099.10","unstructured":"Health Protection Agency. Hepatitis B information. Health Protection Agency, 2003. http:\/\/www.hpa.org.uk\/infections\/topics_az\/hepatitis_b\/gen_info.htm (accessed 25 Mar 2013)."},{"key":"2024051504500506000_3.6.e003099.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.1998.00028.x"},{"key":"2024051504500506000_3.6.e003099.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411002"},{"key":"2024051504500506000_3.6.e003099.13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2296-12-9","article-title":"Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort?","volume":"12","author":"Arnold","year":"2011","journal-title":"BMC Fam Pract"},{"key":"2024051504500506000_3.6.e003099.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.03.020"},{"key":"2024051504500506000_3.6.e003099.15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10459-004-6856-7","article-title":"ROC and loss function analysis in sequential testing","volume":"11","author":"Muijtjens","year":"2006","journal-title":"Adv Health Sci Educ Theory Pract"},{"key":"2024051504500506000_3.6.e003099.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421707"},{"key":"2024051504500506000_3.6.e003099.17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040752"},{"key":"2024051504500506000_3.6.e003099.18","first-page":"2111","article-title":"Evaluating asymptomatic patients with abnormal liver function test results","volume":"53","author":"Theal","year":"1996","journal-title":"Am Fam Physician"},{"key":"2024051504500506000_3.6.e003099.19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1515\/jpme.1990.18.2.77","article-title":"Size of trials for evaluation of antenatal tests of fetal wellbeing in high risk pregnancy","volume":"18","author":"De Bono","year":"1990","journal-title":"J Perinat Med"},{"key":"2024051504500506000_3.6.e003099.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e686"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-003099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:50:48Z","timestamp":1715788248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-003099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"alternative-id":["10.1136\/bmjopen-2013-003099"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-003099","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}